Amoxicillin and the Penicillin Family Explained

Amoxicillin is one of the most widely recognised antibiotics in the world, belonging to a broader class of medicines known as the penicillins. As part of the beta-lactam family, it works by interfering with the construction of bacterial cell walls, ultimately causing the bacteria to rupture and die. Penicillins are used to treat a variety of common bacterial infections, and amoxicillin itself is frequently prescribed for respiratory tract infections, ear infections, and urinary tract infections. Because of its broad applicability and long history of use, it has become a cornerstone of modern outpatient antibiotic therapy.

From Mould to Medicine: A Brief History

The story of penicillin began in 1928 when Scottish bacteriologist Alexander Fleming observed that a mould called *Penicillium notatum* had destroyed staphylococci bacteria in a petri dish. It took over a decade, and the collaborative work of scientists Howard Florey and Ernst Chain, to isolate and mass-produce penicillin, eventually transforming it into a life-saving medicine during the Second World War. Natural penicillin had limitations, however, including poor absorption when taken orally and susceptibility to bacterial enzymes that could destroy it.

In the decades that followed, scientists modified the original penicillin structure to create semi-synthetic variants. Amoxicillin was introduced in the early 1970s as an improved version of its close relative, ampicillin. It offered better absorption from the digestive tract, making it highly effective when taken as a pill or liquid suspension, which greatly increased its practical use in everyday outpatient care.

Why Amoxicillin is an Essential Medicine

The World Health Organization (WHO) maintains an Essential Medicines List (EML), which catalogues the medicines considered most necessary for a basic health system. Amoxicillin features prominently on this list because it is highly effective against a wide range of common bacteria, generally well-tolerated, and relatively inexpensive to produce. It is also versatile; it can be administered orally, which is particularly valuable in outpatient and community settings where intravenous treatments are impractical.

Furthermore, amoxicillin is frequently paired with a secondary medicine called clavulanic acid. Clavulanic acid acts as an inhibitor, protecting amoxicillin from the bacterial enzymes that would otherwise destroy it, thereby extending its usefulness to infections that would normally resist the drug. In South Africa, amoxicillin is similarly prioritised within the public health system, and its registered products and Single Exit Price can be reviewed using HealthSA.

Resistance and the Need for Stewardship

Despite its enduring usefulness, amoxicillin's effectiveness is threatened by antimicrobial resistance (AMR). Bacteria can evolve to produce beta-lactamase enzymes, which break down the beta-lactam ring structure that gives penicillins their antibacterial properties. When bacteria become resistant, infections become harder to treat, leading to longer illnesses, more complex hospital care, and higher medical costs.

This is why antibiotic stewardship—using antibiotics only when necessary and avoiding their use for conditions where they provide no benefit—is heavily promoted by health regulators globally. The WHO consistently highlights the importance of preserving the effectiveness of existing antibiotics like amoxicillin. Relying on the development of new antibiotics is not a sustainable strategy, making the protection of current medicines critical.

Prescription-Only Status

To curb the rise of resistance and ensure patient safety, amoxicillin is classified as a prescription-only medicine in most countries. In South Africa, the South African Health Products Regulatory Authority (SAHPRA) regulates antibiotics under Schedule 4 of the Medicines and Related Substances Act. This means a pharmacist cannot legally dispense amoxicillin without a valid prescription from an authorised prescriber.

This regulatory control prevents the inappropriate use of antibiotics for viral infections—such as the common cold or flu—against which they have no effect. It also reduces the likelihood of bacteria encountering the drug unnecessarily, which is a primary driver of resistance. By keeping amoxicillin strictly behind the pharmacy counter, regulators aim to protect its clinical usefulness for future generations.